Category:Pharmaceutical

One winter evening in 1804, in the back of a small apothecary's shop in Westphalia, the twenty-year-old assistant Friedrich Sertürner isolated a pure white crystalline powder from a watery extract of opium poppy and named it morphium, after the god of dreams.^[1] It was the first plant alkaloid ever isolated in pure form. The apothecary's bench remained the everyday locus of medicine-making for another century, but Sertürner's crystals marked the beginning of a path on which medicines stopped being plants and started being molecules: identifiable, purifiable, eventually synthesizable, and ultimately manufacturable at industrial scale.

The pharmaceutical category collects medicines whose active material is currently produced by industrial manufacture: by chemical synthesis, by biotechnology and recombinant production, by fermentation, or by semi-synthesis from a natural precursor. The category is about the source of the medicine today, not about its history. A great many medicines now made in pharmaceutical plants began as plant extracts: morphine from the opium poppy, aspirin from willow bark, ephedrine from ephedra, the vinca alkaloids from Catharanthus, paclitaxel from Pacific yew, digoxin from foxglove. Each of those pages can sit simultaneously in this category and in Plant; the wiki's framing is that a medicine can belong to both at once, with a `derived_from` field recording the botanical, animal, fungal, or mineral origin where one exists. The category tracks present-tense production; the field tracks lineage.

The pharmaceutical industry as it now exists is roughly a century and a half old. Its prehistory is the alkaloid-isolation work of the early nineteenth century, after Sertürner, by people working in much the same apothecaries' back rooms. The French chemists Pierre-Joseph Pelletier and Joseph Bienaimé Caventou, working together at the École de Pharmacie in Paris, isolated caffeine in 1819 and quinine in 1820, and went on through the decade to isolate strychnine, brucine, and several other plant alkaloids; the German pharmacist Heinrich Friedrich Georg Mein isolated atropine from belladonna in 1833; the German chemist Albert Niemann isolated cocaine from coca leaf in 1859.^[2] Each of these isolations made it possible, in principle, to give a patient a known quantity of a known molecule rather than a variable quantity of a plant extract. The implications for clinical reproducibility were transformative.

The industrial form of the work began in the German dye industry of the late nineteenth century. Companies originally founded to make synthetic colours, Bayer, Hoechst, Merck, and others, pivoted to medicines as their chemists discovered that the same techniques produced pharmacologically active compounds. The early successes were striking: aspirin (acetylsalicylic acid, synthesized in usable form by Bayer chemist Felix Hoffmann in 1897 and marketed from 1899);^[3] barbital (the first barbiturate, Bayer, Fischer and von Mering 1903);^[2] Salvarsan (Paul Ehrlich and Sahachiro Hata's organoarsenic for syphilis, Hoechst 1909), which Ehrlich himself promoted as the founding example of the "magic bullet" concept of selective chemotherapy.^[4] The pharmaceutical industry of the twentieth century, with its randomised controlled trials, its regulatory agencies, its patents, and its global reach, grew from that root.

Modern pharmaceutical manufacturing operates inside a regulatory framework built over the twentieth century: the United States Pure Food and Drug Act of 1906 and the founding of the Food and Drug Administration, the European Medicines Agency (founded 1995), the United Kingdom's Medicines and Healthcare products Regulatory Agency, Japan's Pharmaceuticals and Medical Devices Agency, and the international harmonisation work of the International Council for Harmonisation since 1990. The same molecule prepared in a kitchen and prepared in a regulated facility are pharmacologically identical, but only the second is a pharmaceutical in the legal and clinical sense the wiki uses here. The category boundary tracks this convention.

Modern pharmaceutical manufacturing now spans several modalities:

• Classical small-molecule chemical synthesis, still the source of most prescription medicines.
• Semi-synthesis from natural precursors, the route by which most opioids (heroin from morphine; oxycodone from thebaine), most steroids (from diosgenin or stigmasterol), and several anti-cancer agents are produced.
• Recombinant protein expression in bacterial, yeast, or mammalian cell culture, which produces the modern insulins, growth factors, monoclonal antibodies, and many of the GLP-1 receptor agonists.
• Fermentation, which produces most antibiotics and many small-molecule biosynthetics.
• The newer modalities: oligonucleotide therapeutics, mRNA medicines, gene-therapy vectors, cell therapies.

The pharmaceutical root collects, as parent, the major class categories that organise the wiki's content. Most medicine pages sit in one or more of these classes in addition to the Pharmaceutical root.

Neurology, psychiatry, and pain:

• Opioids, the family of analgesics acting at the µ-opioid receptor and related targets. Both natural-origin (codeine, morphine, thebaine) and synthetic (fentanyl, methadone, oxycodone) members. Multi-membership with Plant for the opium-poppy-derived members.
• Benzodiazepines, the GABA-A positive allosteric modulators.
• Antidepressants, including the SSRIs, SNRIs, TCAs, MAOIs, and newer agents.
• Neuroleptics (antipsychotics), first-, second-, and third-generation.
• Mood stabilizers, including lithium, valproate, carbamazepine, lamotrigine.
• Anesthetics, the inhalational and intravenous general anesthetics plus local anesthetics.
• Anticonvulsants.
• Anti-dementia medicines (acetylcholinesterase inhibitors, NMDA antagonists, anti-amyloid antibodies).
• Antiparkinsonian medicines.
• Migraine medicines (triptans, gepants, ditans, ergotamines).
• Psychostimulants, multi-membership with Plant for the naturally-occurring stimulants.
• Eugeroics, the wakefulness-promoting agents.
• Sedative-hypnotics, including the Z-drugs and orexin antagonists.
• Barbiturates.
• NSAIDs.
• Muscle relaxants and Neuromuscular blockers.

Cardiovascular and metabolic:

• Beta blockers.
• GLP-1 receptor agonists.
• Antidiabetic medicines.
• Anti-obesity medicines.
• PDE5 inhibitors.
• Antihypertensives (ACE inhibitors, ARBs, calcium channel blockers, thiazide and loop diuretics): no dedicated wiki category yet; flagged for creation. The wiki currently catalogues individual antihypertensive medicines but lacks the class umbrella.
• Lipid-modifying agents (statins, fibrates, PCSK9 inhibitors, ezetimibe): no dedicated wiki category yet; flagged for creation.

Infection:

• Antibiotics (penicillins, cephalosporins, macrolides, fluoroquinolones, tetracyclines, aminoglycosides, glycopeptides, oxazolidinones, lipopeptides): no dedicated wiki category yet; flagged for creation. A conspicuous gap given the historical centrality of antibiotic chemistry to the pharmaceutical industry.
• Antifungals (azoles, polyenes, echinocandins, allylamines): no dedicated wiki category yet; flagged for creation.
• Antivirals (nucleoside and non-nucleoside analogs, protease inhibitors, integrase inhibitors, neuraminidase inhibitors, direct-acting antivirals for HCV, antiretrovirals broadly): no dedicated wiki category yet; flagged for creation.

Oncology:

• Anti-cancer / antineoplastic medicines (alkylating agents, anti-metabolites, taxanes, vinca alkaloids, anthracyclines, platinum agents, tyrosine kinase inhibitors, monoclonal antibodies, immune checkpoint inhibitors, CAR-T therapies): no dedicated wiki category yet; flagged for creation.

Hormones and endocrine:

• Hormonal therapies (insulins, glucocorticoids, mineralocorticoids, thyroid hormones, sex steroids, somatostatin analogs, pituitary peptides): no dedicated wiki category yet; flagged for creation.

Cross-axis with Plant root:

• Cannabinoids, multi-membership with Plant for the cannabis-derived members.
• Phenethylamines and the 2C-x series, multi-membership with Plant for the mescaline subset.
• Tryptamines, multi-membership with Plant for psilocybin, DMT, ibogaine, and related natural members.

This list is not exhaustive; the wiki carries roughly 150 class categories in total. A full audit lives at the Phase 2 retag log.

Many medicines on the pharmaceutical side have living counterparts on the Plant side, either as the historical source of the molecule or as a parallel modern use of the plant itself. The convention on this wiki is that:

• The Pharmaceutical category tracks the medicine's current source as a manufactured material.
• The Plant category tracks medicines whose current source is a plant or other botanical, fungal, or animal material.
• Pages whose subject can reasonably claim both are tagged into both.
• Individual medicine pages may declare a `derived_from` field referencing the source organism page, so a reader on Codeine can find their way to Opium and a reader on Aspirin can find their way to Willow.

The two roots are not exclusive and not competing; they index the same underlying material world from two angles. A medicine that began as a plant alkaloid two hundred years ago and is now produced in a fermentation tank is in both categories, and that is the right answer.